ABSTRACT Objectives: to analyze the assistance strategies in palliative care developed in the COVID-19 pandemic for critically ill patients and their families. Methods: an integrative review carried out in August 2021 and updated in April 2022 in the Base de Dados de Enfermagem (BDENF), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medical Literature Analysis and Retrieval System Online (MEDLINE), US National Library of Medicine (PubMed), Web of Science databases, and presented in the PRISMA flowchart. Results: thirteen works were selected for reading and content analysis, from which emerged the two main themes that reflect the reality evidenced in this context: The sudden advent of COVID-19 with impacts on palliative care; and The strategies used in palliative care to mitigate these impacts. Final Considerations: palliative care is the best strategy for providing health care, used as a comfort to bring relief and comfort to patients and families.

RESUMEN Objetivos: analizar las estrategias asistenciales en cuidados paliativos desarrolladas en la pandemia de COVID-19 para pacientes críticos y sus familias. Métodos: revisión integradora, realizada en agosto de 2021 y actualizada en abril de 2022, en las bases de datos Base de Dados de Enfermagem (BDENF), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medical Literature Analysis and Retrieval System Online (MEDLINE), US National Library of Medicine (PubMed), Web of Science, y presentado en el diagrama de flujo PRISMA. Resultados: se seleccionaron trece obras para lectura y análisis de contenido, de las cuales surgieron dos temas principales que reflejan la realidad evidenciada en este contexto: El advenimiento repentino de la COVID-19 con impactos en los cuidados paliativos; y Las estrategias utilizadas en cuidados paliativos para mitigar estos impactos. Consideraciones Finales: los cuidados paliativos son la mejor estrategia para brindar atención en salud, utilizados como un consuelo para brindar alivio y comodidad a los pacientes y familiares”.

RESUMO Objetivos: analisar as estratégias assistenciais em cuidados paliativos desenvolvidas na pandemia de COVID-19 aos pacientes graves e familiares. Métodos: revisão integrativa, realizada em agosto de 2021 e atualizada em abril de 2022, nas bases de dados Base de Dados de Enfermagem (BDENF), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medical Literature Analysis and Retrieval System Online (MEDLINE), US National Library of Medicine (PubMed), Web of Science, e apresentadas no fluxograma PRISMA. Resultados: foram selecionados treze trabalhos para leitura e análise de conteúdo, dos quais emergiram as duas principais temáticas que traduzem a realidade evidenciada neste contexto: O advento súbito da COVID-19 com impactos nos cuidados paliativos; e, As estratégias utilizadas em cuidados paliativos para amenizar esses impactos. Considerações Finais: os cuidados paliativos se convergem na melhor estratégia de prestação de atendimento à saúde, usados como um acalento para trazer alívio e conforto aos pacientes e às famílias.

Background: So that an improvement in the selection of donors can be achieved and the risk to the recipient of transfused blood can be reduced, prospective donors are submitted to clinical and serological screening. Objective: This study investigated the blood discard rate and the rate of infectious and contagious diseases in blood donors from provincial towns of the state of Paraná, Brazil. Methods: This study was an exploratory cross-sectional descriptive investigation with a quantitative approach of donations between January and December 2011. Results: In the study period the Regional Blood center in Maringá, Brazil received 8337 blood donations from people living in the city and neighboring towns. However, 278 (3.33%) donations were discarded during serological screening owing to one or more positive serological markers. A total of 46.4% of the discarded blood units were confirmed positive by serology with anti-HBc being the most common (66.7%), followed by syphilis (22.5%), HBsAg (4.7%), anti-hepatitis C virus (3.1%), human immunodeficiency virus (1.5%) and Chagas' disease (1.5%). The rate of infectious-contagious diseases that can be transmitted by blood transfusions was 1.55% (129/8337) of the donor population with a frequency of 1.03% for anti-HBc and 0.35% for syphilis. Conclusion: This study demonstrates a high prevalence of the anti-HBc marker in prospective blood donors from provincial towns in the state of Paraná, Brazil.